獸醫影像市場機會、成長動力、產業趨勢分析及 2025 - 2034 年預測

2024 年全球獸醫影像市場價值為 21 億美元，預計到 2034 年將以 6.6% 的複合年成長率成長，達到 40 億美元。動物疾病發病率的不斷上升以及動物保健領域對準確、非侵入性診斷的日益成長的偏好，推動了該市場的顯著成長。隨著獸醫護理變得越來越先進，影像系統正在成為早期疾病檢測和治療計劃的重要工具。數位放射成像、超音波、電腦斷層掃描 (CT) 和磁振造影 (MRI) 等成像方式的創新提高了診斷的精確度和速度，使獸醫能夠更準確地識別問題並及時採取干涉措施。寵物主人，尤其是較已開發地區的寵物主人，越來越傾向於為他們的動物提供與人類醫學相同水平的護理，這推動了對獸醫成像技術的需求。

對動物保健基礎設施的投資不斷增加以及對診斷技術的認知不斷提高也促進了市場的上升趨勢。影像系統在獸醫研究和培訓機構中也發揮關鍵作用，進一步支持它們融入主流獸醫實踐。影像工具在早期識別腫瘤和肌肉骨骼疾病等疾病方面的應用日益廣泛，鞏固了其在現代獸醫護理中的作用。從本質上講，獸醫成像對於提供高品質的護理來說正變得越來越不可或缺，其日益成長的重要性反映在世界範圍內採用率的不斷提高。

根據產品細分，市場包括獸醫成像儀器、軟體和試劑。其中，獸醫成像儀器佔據主導地位，2024 年價值為 12 億美元。該領域包括各種技術，例如放射系統、超音波系統、CT 掃描儀、MRI 機器、視訊內視鏡裝置、核成像設備和其他成像平台。獸醫診所擴大採用這些系統來診斷各種健康狀況。人們對早期疾病檢測的認知不斷提高，加上允許更高解析度成像和更快處理時間的進步，正在加速將這些工具整合到日常獸醫操作中。寵物收養數量的成長、獸醫診所數量的激增以及對動物健康的日益重視，進一步提升了對影像儀器的需求。

根據動物類型，市場分為小型伴侶動物、大型動物和其他動物。 2024 年，小型伴侶動物市場以 49% 的市佔率領先全球市場。這個類別包括狗和貓等動物，它們的數量正在顯著增加，尤其是在城市家庭中。隨著人們對寵物健康的日益關注和獲得獸醫服務的增加，寵物主人在醫療診斷和治療上的花費也越來越多。此外，寵物保險覆蓋範圍的擴大使得獸醫支出增加，從而支持該領域在預測期內持續成長。

在應用方面，市場分為骨科和創傷科、腫瘤科、心臟科、神經科等。骨科和創傷學領域是領先的應用領域，預計到 2034 年將產生 14 億美元的產值。對損傷和肌肉骨骼疾病的精確診斷成像的需求日益成長，推動了該領域的需求。 X 光、MRI 和 CT 掃描等技術被廣泛用於評估骨骼、關節和韌帶的狀況。提供清晰、詳細的視覺效果有助於準確的診斷並有助於規劃有效的治療，這是該領域強大的市場佔有率的關鍵因素。此外，向微創治療的轉變正在鼓勵採用先進的影像解決方案。

根據最終用途，市場包括獸醫醫院和診所、診斷影像中心和其他場所。獸醫院和診所佔據了 2024 年最大的市場佔有率，預計到 2034 年將以 6.4% 的複合年成長率成長。這些機構擁有更多資源投資於成像系統，並且通常是第一個採用新技術的機構。政府支持發展現代化醫療基礎設施的措施也增強了獲得先進獸醫服務的機會。醫院和診所擴大將高階診斷工具整合到他們的服務中，以提供更好的結果並提高護理質量，從而推動該領域的市場成長。

光是美國獸醫成像市場在 2024 年就達到 8.18 億美元，佔全球市場的很大佔有率。這一成長是由完善的醫療保健框架、對先進獸醫診斷的高需求以及主要市場參與者的強大影響力所推動的。寵物擁有量的增加以及獸醫實踐中高科技診斷解決方案的採用正在加強該國在全球地位。人們對寵物健康的認知不斷提高，對早期疾病診斷的關注度不斷提高，並繼續支持美國影像技術的推廣

這個競爭激烈的市場中的知名公司包括愛克發吉華集團、BCF、佳能醫療系統公司、銳珂醫療、Epica International、百勝、EI Medical Imaging、富士膠片控股公司、通用電氣醫療集團、赫斯卡公司、愛德士實驗室、IMV Imaging、柯尼卡美能達、深邁邁子庫、深邁子醫療技術有限公司和西邁子。這些公司正在跨產品線進行創新，整合人工智慧技術，並專注於開發攜帶式、高效的成像設備。戰略合作夥伴關係和新地域擴張也幫助他們加強了全球市場影響力。

目錄

第1章：方法論與範圍

第2章：執行摘要

第3章：行業洞察

• 產業生態系統分析
• 產業衝擊力
  • 成長動力
    • 寵物擁有量和支出增加
    • 成像技術的進步
    • 動物疾病發生率上升
    • 已開發經濟體獸醫數量不斷增加
  • 產業陷阱與挑戰
    • 獸醫影像儀器成本高昂
• 成長潛力分析
• 監管格局
• 技術格局
• 未來市場趨勢
• 波特的分析
• PESTEL分析

第4章：競爭格局

• 介紹
• 公司矩陣分析
• 主要市場參與者的競爭分析
• 競爭定位矩陣
• 策略儀表板

第5章：市場估計與預測：按產品，2021 - 2034 年

• 主要趨勢
• 獸醫成像儀器
  • 放射線照相（X光）系統
  • 超音波系統
  • 電腦斷層掃描系統
  • 磁振造影系統
  • 視訊內視鏡成像系統
  • 核子造影掃描儀
  • 其他成像系統
• 獸醫軟體
• 獸醫成像試劑
  • 超音波造影試劑
  • MRI造影劑
  • X光/CT造影試劑
  • 核子造影試劑

第6章：市場估計與預測：依動物類型，2021 - 2034 年

• 主要趨勢
• 小型伴侶動物
  • 狗
  • 貓
  • 其他小型伴侶動物
• 大型動物
  • 馬
  • 牛
  • 其他大型動物
• 其他動物

第7章：市場估計與預測：按應用，2021 - 2034 年

• 主要趨勢
• 骨科和創傷學
• 腫瘤學
• 心臟病學
• 神經病學
• 其他應用

第8章：市場估計與預測：依最終用途，2021 - 2034 年

• 主要趨勢
• 獸醫醫院和診所
• 診斷影像中心
• 其他最終用途

第9章：市場估計與預測：按地區，2021 - 2034 年

• 主要趨勢
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 英國
  • 法國
  • 義大利
  • 西班牙
  • 荷蘭
• 亞太地區
  • 中國
  • 日本
  • 印度
  • 澳洲
  • 韓國
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
• 中東和非洲
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第10章：公司簡介

• Agfa-Gevaert Group
• BCF
• Canon Medical Systems Corporation
• Carestream Health
• Epica International
• Esaote
• EI Medical Imaging
• Fujifilm Holdings Corporation
• GE Healthcare
• Heska Corporation
• IDEXX Laboratories
• IMV imaging
• Konica Minolta
• Shenzhen Mindray Animal Medical Technology
• Siemens Healthineers

The Global Veterinary Imaging Market was valued at USD 2.1 billion in 2024 and is estimated to grow at a CAGR of 6.6% to reach USD 4 billion by 2034. The increasing incidence of animal diseases and the rising preference for accurate, non-invasive diagnostics in animal healthcare are driving significant growth in this market. With veterinary care becoming more advanced, imaging systems are emerging as essential tools for early disease detection and treatment planning. Innovations in imaging modalities such as digital radiography, ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI) have enhanced the precision and speed of diagnostics, allowing veterinarians to identify issues with greater accuracy and initiate timely interventions. Pet owners, especially in more developed regions, are increasingly inclined toward offering their animals the same level of care expected in human medicine, boosting the demand for veterinary imaging technologies.

Growing investments in animal healthcare infrastructure and heightened awareness around diagnostic technologies are also contributing to the market's upward trajectory. Imaging systems are playing a critical role in veterinary research and training institutions as well, further supporting their integration into mainstream veterinary practices. The expanding application of imaging tools for the early identification of conditions like tumors and musculoskeletal disorders is solidifying their role in modern veterinary care. In essence, veterinary imaging is becoming indispensable for offering high-quality care, and its growing significance is reflected in the increasing adoption rates worldwide.

The market, based on product segmentation, includes veterinary imaging instruments, software, and reagents. Among these, veterinary imaging instruments held the dominant share, valued at USD 1.2 billion in 2024. This segment includes a variety of technologies, such as radiography systems, ultrasound systems, CT scanners, MRI machines, video endoscopy units, nuclear imaging devices, and other imaging platforms. These systems are being increasingly adopted across veterinary clinics to diagnose a wide range of health conditions. Rising awareness around early disease detection, combined with advances that allow higher-resolution imaging and faster processing times, is accelerating the integration of these tools into daily veterinary operations. The growth in pet adoption, the surge in veterinary clinic openings, and the heightened emphasis on animal health are further elevating the demand for imaging instruments.

When examined by animal type, the market is categorized into small companion animals, large animals, and others. The small companion animals segment led the global market in 2024 with a 49% share. This category includes animals such as dogs and cats, which are experiencing a notable rise in population, particularly in urban households. With growing attention to pet health and increased access to veterinary services, pet owners are spending more on medical diagnostics and treatments. Additionally, the expansion of pet insurance coverage is enabling higher veterinary expenditure, supporting sustained growth in this segment through the forecast period.

In terms of application, the market is segmented into orthopedics and traumatology, oncology, cardiology, neurology, and others. The orthopedics and traumatology segment stood out as the leading application area, and it is expected to generate USD 1.4 billion by 2034. The increasing need for precise diagnostic imaging for injuries and musculoskeletal disorders is fueling demand in this segment. Technologies such as X-rays, MRI, and CT scans are extensively used to evaluate conditions involving bones, joints, and ligaments. The ability to deliver clear, detailed visuals supports accurate diagnoses and aids in planning effective treatments, which is a key factor behind the strong market share of this segment. Additionally, the shift toward minimally invasive treatments is encouraging the adoption of advanced imaging solutions.

Based on end use, the market includes veterinary hospitals and clinics, diagnostic imaging centers, and other settings. Veterinary hospitals and clinics accounted for the largest market share in 2024 and are anticipated to grow at a CAGR of 6.4% through 2034. These facilities have more resources to invest in imaging systems and are typically the first to adopt new technologies. Government initiatives supporting the development of modern healthcare infrastructure are also enhancing access to advanced veterinary services. Hospitals and clinics are increasingly integrating high-end diagnostic tools into their services to deliver better outcomes and elevate the quality of care, fueling market growth in this segment.

The U.S. veterinary imaging market alone reached USD 818 million in 2024, holding a major share of the global market. This growth is driven by a well-developed healthcare framework, high demand for advanced veterinary diagnostics, and a strong presence of leading market players. The rise in pet ownership and the adoption of high-tech diagnostic solutions across veterinary practices are strengthening the country's position in the global landscape. Greater awareness of pet health and a growing focus on early disease diagnosis continue to support the expansion of imaging technologies in the U.S.

Prominent companies in this competitive market include Agfa-Gevaert Group, BCF, Canon Medical Systems Corporation, Carestream Health, Epica International, Esaote, E.I. Medical Imaging, Fujifilm Holdings Corporation, GE Healthcare, Heska Corporation, IDEXX Laboratories, IMV imaging, Konica Minolta, Shenzhen Mindray Animal Medical Technology, and Siemens Healthineers. These companies are innovating across product lines, integrating AI technologies, and focusing on developing portable and efficient imaging devices. Strategic partnerships and expansions into new geographies are also helping them strengthen their global market presence.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definition
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360⁰ synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing pet ownership and expenditure
    • 3.2.1.2 Advancements in imaging technologies
    • 3.2.1.3 Rising prevalence of animal diseases
    • 3.2.1.4 Rising number of veterinary practitioners in developed economies
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost associated with veterinary imaging instruments
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Technology landscape
• 3.6 Future market trends
• 3.7 Porter’s analysis
• 3.8 PESTEL analysis

Chapter 4 Competitive Landscape, 2024

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2034 ($ Mn)

• 5.1 Key trends
• 5.2 Veterinary imaging instruments
  • 5.2.1 Radiography (X-ray) systems
  • 5.2.2 Ultrasound systems
  • 5.2.3 Computed tomography systems
  • 5.2.4 Magnetic resonance imaging systems
  • 5.2.5 Video endoscopy imaging systems
  • 5.2.6 Nuclear imaging scanners
  • 5.2.7 Other imaging systems
• 5.3 Veterinary software
• 5.4 Veterinary imaging reagents
  • 5.4.1 Ultrasound contrast reagents
  • 5.4.2 MRI contrast reagents
  • 5.4.3 X-ray/CT contrast reagents
  • 5.4.4 Nuclear imaging reagents

Chapter 6 Market Estimates and Forecast, By Animal Type, 2021 - 2034 ($ Mn)

• 6.1 Key trends
• 6.2 Small companion animals
  • 6.2.1 Dogs
  • 6.2.2 Cats
  • 6.2.3 Other small companion animals
• 6.3 Large animals
  • 6.3.1 Horse
  • 6.3.2 Cattle
  • 6.3.3 Other large animals
• 6.4 Other animals

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2034 ($ Mn)

• 7.1 Key trends
• 7.2 Orthopedics and traumatology
• 7.3 Oncology
• 7.4 Cardiology
• 7.5 Neurology
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End Use, 2021 - 2034 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinary hospitals and clinics
• 8.3 Diagnostic imaging centers
• 8.4 Other end use

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2034 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
• 9.6 Middle East and Africa
  • 9.6.1 South Africa
  • 9.6.2 Saudi Arabia
  • 9.6.3 UAE

Chapter 10 Company Profiles

• 10.1 Agfa-Gevaert Group
• 10.2 BCF
• 10.3 Canon Medical Systems Corporation
• 10.4 Carestream Health
• 10.5 Epica International
• 10.6 Esaote
• 10.7 E.I. Medical Imaging
• 10.8 Fujifilm Holdings Corporation
• 10.9 GE Healthcare
• 10.10 Heska Corporation
• 10.11 IDEXX Laboratories
• 10.12 IMV imaging
• 10.13 Konica Minolta
• 10.14 Shenzhen Mindray Animal Medical Technology
• 10.15 Siemens Healthineers